CJC-1295 + DAC 5mg
CJC-1295 with Drug Affinity Complex (DAC) is a synthetic growth hormone-releasing hormone (GHRH) analogue engineered to provide prolonged receptor interaction through reversible binding to circulating albumin. This modification substantially extends the peptide’s persistence under experimental conditions compared to non-DAC GHRH analogues, making CJC-1295 + DAC an important research tool for investigating sustained GHRH receptor activation, endocrine signaling, and peptide pharmacokinetics.
In controlled laboratory environments, CJC-1295 + DAC is commonly evaluated for its interaction with the growth hormone-releasing hormone receptor (GHRHR) and the downstream signaling pathways associated with pituitary peptide secretion. Investigational applications may include studies involving the GH/IGF-1 axis, receptor activation kinetics, JAK/STAT signaling, endocrine feedback regulation, pulsatile hormone secretion, peptide half-life extension, protein synthesis, cellular metabolism, skeletal muscle physiology, connective tissue biology, and metabolic homeostasis. Researchers also utilize CJC-1295 + DAC to investigate albumin-binding technologies, prolonged peptide exposure, receptor pharmacology, and structure-activity relationships across a variety of in vitro and preclinical experimental models.
Due to its extended biological persistence and well-characterized receptor pharmacology, CJC-1295 + DAC has become a valuable analytical reagent for laboratory investigations involving endocrine physiology, peptide engineering, metabolic regulation, and long-acting peptide therapeutics. Experimental findings remain dependent upon laboratory design, model selection, and controlled research conditions and should not be interpreted as established therapeutic outcomes.
Supplied in a 5 mg lyophilized presentation, CJC-1295 + DAC is suitable for analytical and investigational laboratory workflows. Each vial is provided as a white lyophilized powder with purity exceeding 99% as verified by HPLC testing. Third-party analytical verification and corresponding certificates of analysis are provided where applicable.
Specifications
Size: 5 mg
Compound Type: Synthetic GHRH analogue
Modification: Drug Affinity Complex (DAC)
Form: Lyophilized powder
Purity: >99% (HPLC verified)
Storage: Store at -20°C away from light and moisture. Reconstitute only under appropriate laboratory conditions using standard research protocols.
Intended Use
This product is supplied strictly for laboratory research purposes only and is intended for use by qualified professionals in controlled scientific environments. It is not for human or animal consumption and is not intended for therapeutic, diagnostic, veterinary, cosmetic, or food use. All handling and use must comply with applicable institutional and regulatory guidelines.
FDA Disclaimer
The statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Products offered are not intended to diagnose, treat, cure, or prevent any disease. Alamo Peptides operates solely as a supplier of research materials and analytical reagents. We are not a pharmacy, outsourcing facility, or pharmaceutical manufacturer. All products are intended exclusively for research use only. By purchasing, customers acknowledge responsibility for proper handling, use, and compliance with all applicable laws and regulations.
Terms of Sale
All sales are final due to the nature of research materials. Purchasers must be 21 years of age or older. Improper use voids any warranties. Alamo Peptides assumes no liability for misuse or improper application of supplied materials.
